4//SEC Filing
BIOGEN INC. 4
Accession 0001127602-17-023131
$BIIBCIK 0000875045operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 7:18 PM ET
Size
5.8 KB
Accession
0001127602-17-023131
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Kress Jean-Paul
EVP Pres Int'l & Global Hd GTO
Transactions
- Award
Restricted Stock Unit
2017-07-03+4,660→ 4,660 totalExercise: $0.00Exp: 2020-07-03→ Common Stock (4,660 underlying)
Footnotes (1)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 7:18 PM ET
- Size
- 5.8 KB